Table 3.
Baseline Characteristic | Fructan Sensitive (n=12) | Fructan Insensitive (n=11) |
---|---|---|
Pain Frequency (episodes/day) | 2.8 ± 2.4 | 2.6 ± 1.8 |
Pain Severity (0–10) a | 1.6 ± 1.0 | 2.2 ± 1.5 |
Bloating (0–10) b | 1.0 ± 1.0 | 0.8 ± 0.8 |
Gas (0–10) b | 0.8 ± 0.8 | 2.0 ± 1.4 # |
Nausea (0–10) b | 0.2 ± 0.2 | 0.3 ± 0.6 |
Fatigue (0–10) b | 1.9 ± 1.8 | 1.5 ± 1.8 |
Bowel movements per day | 0.9 ± 0.5 | 0.9 ± 0.4 |
Mean Stool Type (1–5) | 2.5 ± 0.6 | 2.5 ± 0.7 |
Somatization c | 31.1 ± 17.9 | 30.5 ± 12.6 |
Depression (T-score) d | 49.3 ± 10.9 | 50.6 ± 9.4 |
Anxiety (T-score) d | 55.5 ± 16.4 | 57.5 ± 13.4 |
P<0.05 comparison between fructan sensitive and fructan insensitive subjects
Data missing for one individual in fructan sensitive group
Data missing for one individual in each group
Measured using the Childhood Somatization Inventory
Measured using the Behavioral Assessment System for Children-2